Unknown

Dataset Information

0

Nanofiber-based sutures induce endogenous antimicrobial peptide.


ABSTRACT:

Aim

The aim of this study was to develop nanofiber-based sutures capable of inducing endogenous antimicrobial peptide production.

Methods

We used co-axial electrospinning deposition and rolling to fabricate sutures containing pam3CSK4 peptide and 25-hydroxyvitamin D3 (25D3).

Results

The diameters and mechanical properties of the sutures were adjustable to meet the criteria of United States Pharmacopeia designation. 25D3 exhibited a sustained release from nanofiber sutures over 4 weeks. Pam3CSK4 peptide also showed an initial burst followed by a sustained release over 4 weeks. The co-delivery of 25D3 and pam3CSK4 peptide enhanced cathelicidin antimicrobial peptide production from U937 cells and keratinocytes compared with 25D3 delivery alone. In addition, the 25D3/pam3CSK4 peptide co-loaded nanofiber sutures did not significantly influence proliferation of keratinocytes, fibroblasts, or the monocytic cell lines U937 and HL-60.

Conclusion

The use of 25D3/pam3CSK4 peptide co-loaded nanofiber sutures could potentially induce endogenous antimicrobial peptide production and reduce surgical site infections.

SUBMITTER: Chen S 

PROVIDER: S-EPMC5674207 | biostudies-literature | 2017 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Nanofiber-based sutures induce endogenous antimicrobial peptide.

Chen Shixuan S   Ge Liangpeng L   Gombart Adrian F AF   Shuler Franklin D FD   Carlson Mark A MA   Reilly Debra A DA   Xie Jingwei J  

Nanomedicine (London, England) 20170929 21


<h4>Aim</h4>The aim of this study was to develop nanofiber-based sutures capable of inducing endogenous antimicrobial peptide production.<h4>Methods</h4>We used co-axial electrospinning deposition and rolling to fabricate sutures containing pam3CSK4 peptide and 25-hydroxyvitamin D<sub>3</sub> (25D<sub>3</sub>).<h4>Results</h4>The diameters and mechanical properties of the sutures were adjustable to meet the criteria of United States Pharmacopeia designation. 25D<sub>3</sub> exhibited a sustained  ...[more]

Similar Datasets

| S-EPMC6219435 | biostudies-literature
| S-EPMC4158920 | biostudies-literature
| S-EPMC7673654 | biostudies-literature
| S-EPMC5451297 | biostudies-literature
| S-EPMC7504391 | biostudies-literature
| S-EPMC4583139 | biostudies-other
| S-EPMC4768747 | biostudies-literature
| S-EPMC1150805 | biostudies-other
2024-02-28 | GSE229566 | GEO
| S-EPMC8009276 | biostudies-literature